0001209191-20-060665.txt : 20201127
0001209191-20-060665.hdr.sgml : 20201127
20201127200012
ACCESSION NUMBER: 0001209191-20-060665
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201125
FILED AS OF DATE: 20201127
DATE AS OF CHANGE: 20201127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FEES JESSICA
CENTRAL INDEX KEY: 0001760391
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38459
FILM NUMBER: 201356109
MAIL ADDRESS:
STREET 1: C/O SURFACE ONCOLOGY, ICN.
STREET 2: 50 HAMPSHIRE STREET 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Surface Oncology, Inc.
CENTRAL INDEX KEY: 0001718108
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-714-4096
MAIL ADDRESS:
STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-25
0
0001718108
Surface Oncology, Inc.
SURF
0001760391
FEES JESSICA
C/O SURFACE ONCOLOGY, INC.
50 HAMPSHIRE STREET, 8TH FLOOR
CAMBRIDGE
MA
02139
0
1
0
0
See Remarks
Common Stock
2020-11-25
4
M
0
227
4.136
A
101027
D
Common Stock
2020-11-25
4
M
0
173
4.27
A
101200
D
Common Stock
2020-11-25
4
M
0
982
5.412
A
102182
D
Common Stock
2020-11-25
4
M
0
1
4.27
A
102183
D
Stock Option (Right to Buy)
4.136
2020-11-25
4
M
0
227
0.00
D
2026-12-09
Common Stock
227
455
D
Stock Option (Right to Buy)
4.27
2020-11-25
4
M
0
173
0.00
D
2029-03-01
Common Stock
173
13905
D
Stock Option (Right to Buy)
5.412
2020-11-25
4
M
0
982
0.00
D
2027-06-27
Common Stock
982
2654
D
Stock Option (Right to Buy)
4.27
2020-11-25
4
M
0
1
0.00
D
2029-03-01
Common Stock
1
25999
D
This option shall vest in 48 equal monthly installments after January 1, 2017.
The stock option vests and becomes exercisable in 48 equal monthly installments after November 18, 2018.
This option shall vest in 48 equal monthly installments after July 1, 2017.
The stock option vests and becomes exercisable in 48 equal monthly installments after February 12, 2019.
Title: Principal Accounting Officer, Principal Financial Officer
/s/ Jessica Fees
2020-11-27